BRD9 Antikörper (N-Term) (Biotin)
-
- Target Alle BRD9 Antikörper anzeigen
- BRD9 (Bromodomain Containing 9 (BRD9))
-
Bindungsspezifität
- AA 1-30, N-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser BRD9 Antikörper ist konjugiert mit Biotin
-
Applikation
- Western Blotting (WB), ELISA
- Kreuzreaktivität
- Human, Maus
- Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu Mo
- Produktmerkmale
- BRD9, NT (BRD9, Bromodomain-containing protein 9, Rhabdomyosarcoma antigen MU-RMS-40.8) (Biotin)
- Aufreinigung
- Purified by Protein A affinity chromatography.
- Immunogen
- BRD9 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of human BRD9.
- Isotyp
- IgG
- Top Product
- Discover our top product BRD9 Primärantikörper
-
-
- Applikationshinweise
- Optimal working conditions should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Supplied as a liquid in PBS, pH 7.2.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- -20°C
-
- Target
- BRD9 (Bromodomain Containing 9 (BRD9))
- Andere Bezeichnung
- BRD9 (BRD9 Produkte)
- Synonyme
- LAVS3040 antikoerper, PRO9856 antikoerper, AL022779 antikoerper, zgc:55797 antikoerper, BRD9 antikoerper, bromodomain containing 9 antikoerper, bromodomain containing 9 L homeolog antikoerper, BRD9 antikoerper, Brd9 antikoerper, brd9 antikoerper, brd9.L antikoerper
- NCBI Accession
- NP_001009877
- UniProt
- Q9H8M2
-